These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32264975)

  • 21. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Montreal Cognitive Assessment (MoCA) is superior to the Mini Mental State Examination (MMSE) in detection of Korsakoff's syndrome.
    Oudman E; Postma A; Van der Stigchel S; Appelhof B; Wijnia JW; Nijboer TC
    Clin Neuropsychol; 2014; 28(7):1123-32. PubMed ID: 25249353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years.
    Delgado C; Araneda A; Behrens MI
    Neurologia (Engl Ed); 2019; 34(6):376-385. PubMed ID: 28364958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short Montreal Cognitive Assessment.
    Larner AJ
    J Geriatr Psychiatry Neurol; 2017 Mar; 30(2):104-108. PubMed ID: 28013571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of different operational definitions on mild cognitive impairment rate and MMSE and MoCA performance in transient ischaemic attack and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Cerebrovasc Dis; 2013; 36(5-6):355-62. PubMed ID: 24217342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.
    Lucza T; Karádi K; Kállai J; Weintraut R; Janszky J; Makkos A; Komoly S; Kovács N
    Behav Neurol; 2015; 2015():983606. PubMed ID: 26078489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital Screening for Cognitive Impairment - A Proof of Concept Study.
    Bloniecki V; Hagman G; Ryden M; Kivipelto M
    J Prev Alzheimers Dis; 2021; 8(2):127-134. PubMed ID: 33569558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
    Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
    Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes.
    Gupta A; Goyal A; Rajan R; Vishnu VY; Kalaivani M; Tandon N; Srivastava MVP; Gupta Y
    Diabetes Ther; 2024 May; 15(5):1155-1168. PubMed ID: 38520603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease.
    Freitas S; Simões MR; Alves L; Santana I
    Alzheimer Dis Assoc Disord; 2013; 27(1):37-43. PubMed ID: 22193353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
    Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
    J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Mild Cognitive Impairment Among Community-Dwelling African Americans Using the Montreal Cognitive Assessment.
    Rossetti HC; Smith EE; Hynan LS; Lacritz LH; Cullum CM; Van Wright A; Weiner MF
    Arch Clin Neuropsychol; 2019 Aug; 34(6):809-813. PubMed ID: 30517598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of three cognitive screening tools in a sample of older New Zealanders.
    Cheung G; Clugston A; Croucher M; Malone D; Mau E; Sims A; Gee S
    Int Psychogeriatr; 2015 Jun; 27(6):981-9. PubMed ID: 25603424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets.
    Salvadori E; Cova I; Mele F; Pomati S; Pantoni L
    Aging Clin Exp Res; 2022 Aug; 34(8):1855-1863. PubMed ID: 35441928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.